AAAAAA

   
Results: 1-7 |
Results: 7
CONSTRUCTION AND CHARACTERIZATION OF RETROVIRAL VECTORS FOR INTERLEUKIN-2 GENE-THERAPY
Authors: FAKHRAI H SHAWLER DL VANBEVEREN C LIN H DORIGO O SOLOMON MJ GJERSET RA SMITH L BARTHOLOMEW RM BOGGIANO CA GOLD DP SOBOL RE
Citation: H. Fakhrai et al., CONSTRUCTION AND CHARACTERIZATION OF RETROVIRAL VECTORS FOR INTERLEUKIN-2 GENE-THERAPY, Journal of immunotherapy, 20(6), 1997, pp. 437-448
INTERLEUKIN-2 (IL-2) GENE-THERAPY WITH ALLOGENEIC FIBROBLASTS IN THE CT-26 MODEL OF MURINE COLORECTAL-CARCINOMA
Authors: SHAWLER DL DORIGO O VANBEVEREN C BARTHOLOMEW RM FAKHRAI H SOBOL RE
Citation: Dl. Shawler et al., INTERLEUKIN-2 (IL-2) GENE-THERAPY WITH ALLOGENEIC FIBROBLASTS IN THE CT-26 MODEL OF MURINE COLORECTAL-CARCINOMA, Oncology Reports, 4(1), 1997, pp. 135-138
PRECLINICAL AND CLINICAL-EXPERIENCE OF INTERLEUKIN-2 (IL-2) AND TGF-BETA ANTISENSE GENE-THERAPY
Authors: SOBOL RE SHAWLER D CARSON C GARRETT M VANBEVEREN C MERCOLA D SMITH L BARTHOLOMEW R BROSTOFF S DORIGO O GOLD D CARLO D ROYSTON I FAHKRAI H
Citation: Re. Sobol et al., PRECLINICAL AND CLINICAL-EXPERIENCE OF INTERLEUKIN-2 (IL-2) AND TGF-BETA ANTISENSE GENE-THERAPY, Cancer gene therapy, 4(1), 1997, pp. 69-69
RAS-MEDIATED PHOSPHORYLATION OF A CONSERVED THREONINE RESIDUE ENHANCES THE TRANSACTIVATION ACTIVITIES OF C-ETS1 AND C-ETS2
Authors: YANG BS HAUSER CA HENKEL G COLMAN MS VANBEVEREN C STACEY KJ HUME DA MAKI RA OSTROWSKI MC
Citation: Bs. Yang et al., RAS-MEDIATED PHOSPHORYLATION OF A CONSERVED THREONINE RESIDUE ENHANCES THE TRANSACTIVATION ACTIVITIES OF C-ETS1 AND C-ETS2, Molecular and cellular biology, 16(2), 1996, pp. 538-547
THE TRANSCRIPTION FACTOR PU.1 IS INVOLVED IN MACROPHAGE PROLIFERATION
Authors: CELADA A BORRAS FE SOLER C LLOBERAS J KLEMSZ M VANBEVEREN C MCKERCHER S MAKI RA
Citation: A. Celada et al., THE TRANSCRIPTION FACTOR PU.1 IS INVOLVED IN MACROPHAGE PROLIFERATION, The Journal of experimental medicine, 184(1), 1996, pp. 61-69
INJECTION OF COLON-CARCINOMA PATIENTS WITH AUTOLOGOUS IRRADIATED TUMOR-CELLS AND FIBROBLASTS GENETICALLY-MODIFIED TO SECRETE INTERLEUKIN-2 (IL-2) - A PHASE-I STUDY
Authors: SOBOL RE ROYSTON I FAKHRAI H SHAWLER DL CARSON C DORIGO O GJERSET R GOLD DP KOZIOL J MERCOLA D VANBEVEREN C WILSON D
Citation: Re. Sobol et al., INJECTION OF COLON-CARCINOMA PATIENTS WITH AUTOLOGOUS IRRADIATED TUMOR-CELLS AND FIBROBLASTS GENETICALLY-MODIFIED TO SECRETE INTERLEUKIN-2 (IL-2) - A PHASE-I STUDY, Human gene therapy, 6(2), 1995, pp. 195-204
TRANSCRIPTIONAL ACTIVATION BY THE ETS RELATED TRANSCRIPTION FACTOR PU.1
Authors: MAKI R MCKERCHER S VANBEVEREN C KLEMSZ M PONGUBALA J NAGULAPALLI S ATKINSON M
Citation: R. Maki et al., TRANSCRIPTIONAL ACTIVATION BY THE ETS RELATED TRANSCRIPTION FACTOR PU.1, Journal of leukocyte biology, 1993, pp. 130-130
Risultati: 1-7 |